These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2288719)

  • 41. Evidence accumulating in support of cancer vaccines combined with chemotherapy: a pragmatic review of past and present efforts.
    Sinkovics JG; Horvath JC
    Int J Oncol; 2006 Oct; 29(4):765-77. PubMed ID: 16964374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological inhibition of TGFβ as a strategy to augment the antitumor immune response.
    Hanks BA; Morse MA
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1342-53. PubMed ID: 21154116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Urba WJ
    Cancer Chemother Biol Response Modif; 1992; 13():205-29. PubMed ID: 1382527
    [No Abstract]   [Full Text] [Related]  

  • 44. Biological response modifiers used in cancer biotherapy.
    Kuroki M; Miyamoto S; Morisaki T; Yotsumoto F; Shirasu N; Taniguchi Y; Soma G
    Anticancer Res; 2012 Jun; 32(6):2229-33. PubMed ID: 22641656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conference Scene: Immunotherapy reaches new milestones in cancer eradication.
    Kotlan B; Umansky V; Malyguine AM; Marincola FM; Shurin MR
    Immunotherapy; 2011 Oct; 3(10):1131-7. PubMed ID: 21995567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of drug resistance: biotherapy or chemotherapy?
    Oldham RK
    Cancer Biother Radiopharm; 1998 Apr; 13(2):69-70. PubMed ID: 10850342
    [No Abstract]   [Full Text] [Related]  

  • 47. Biotherapy and the oncology nurse.
    Farrell MM
    Semin Oncol Nurs; 1996 May; 12(2):82-8. PubMed ID: 8727795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Principles of combining biomodulators with cytotoxic agents in vivo.
    Mitchell MS
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):51-6. PubMed ID: 1553575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of prior chemotherapy on biologic response modifier activity.
    Weisenthal LM
    J Natl Cancer Inst; 1991 Jun; 83(11):790-3. PubMed ID: 2041053
    [No Abstract]   [Full Text] [Related]  

  • 50. Retrospective assessment of chemotherapy/biotherapy toxicity in a Hispanic/Latinx population versus published study population.
    Leidy SB; Hull LR; Macik MR; Gonzalvo JD; Weddle KJ
    J Oncol Pharm Pract; 2023 Jan; 29(1):66-73. PubMed ID: 34726099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapeutic regimen influences the results of chemotherapy plus immunotherapy.
    Zhao L
    Immunotherapy; 2019 Oct; 11(15):1259-1261. PubMed ID: 31530053
    [No Abstract]   [Full Text] [Related]  

  • 52. Principles of biotherapy and its application to the treatment of disseminated renal cancer.
    O'Connor TE; West WH; Marshall GD; Orr DW; Lewis M; Oldham RK
    Semin Surg Oncol; 1988; 4(3):155-60. PubMed ID: 3055159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine-based biotherapy of gastrointestinal tumors.
    Buer J; Kirchner H; Schomburg A; Schüler A; Manns M; Lopez-Hänninen E; Duensing S; Poliwoda H; Atzpodien J
    Clin Investig; 1994 Jul; 72(7):526-34. PubMed ID: 7981582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Future projections in biotherapy.
    Rieger PT
    Semin Oncol Nurs; 1996 May; 12(2):163-71. PubMed ID: 8727803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential therapeutic applications of PHA-L4, the mitogenic isolectin of phytohemagglutinin.
    Wimer BM
    Mol Biother; 1990 Dec; 2(4):196-200. PubMed ID: 2288718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale for combining biotherapy in the treatment of advanced colon cancer.
    Cohen DJ; Hochster HS
    Gastrointest Cancer Res; 2008 May; 2(3):145-51. PubMed ID: 19259292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biotherapy for colon cancer: promise or progress?
    Rieger PT
    J Wound Ostomy Continence Nurs; 1994 May; 21(3):111-9. PubMed ID: 7858674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biotherapy: the fourth modality of cancer treatment.
    Oldham RK
    J Cell Physiol Suppl; 1986; 4():91-9. PubMed ID: 2427531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ascorbate combination therapy: new tool in the anticancer toolbox?
    McConnell MJ; Herst PM
    Sci Transl Med; 2014 Feb; 6(222):222fs6. PubMed ID: 24500402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytokines as therapeutics--application in oncology].
    Lasek W; Jakóbisiak M
    Pneumonol Alergol Pol; 1999; 67(11-12):491-6. PubMed ID: 11185035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.